Recombinant human bone morphogenetic protein-2 stimulates osteoblast differentiation and suppresses matrix metalloproteinase-1 production in human bone cells isolated from mandibulae

Journal of Periodontal Research

Volumn 33, Issue 8, 1998, Pages 476-485

  Takiguchi, T ^a   Kobayashi, M ^a   Suzuki, R ^a   Yamaguchi, A ^a   Isatsu, K ^a   Nishihara, T ^b   Nagumo, M ^a   Hasegawa, K ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Bone morphogenetic protein 2; Human bone cells; Matrix metalloproteinase 1; Osteoblast differentiation

Indexed keywords

ALKALINE PHOSPHATASE; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; COLLAGENASE; CYCLIC AMP; INTERSTITIAL COLLAGENASE; OSTEOCALCIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FIBROBLAST; HUMAN; MANDIBLE; METABOLISM; OSTEOBLAST;

ADULT; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; COLLAGEN; COLLAGENASES; CYCLIC AMP; ENZYME INDUCTION; FIBROBLASTS; HUMANS; MANDIBLE; MATRIX METALLOPROTEINASE 1; OSTEOBLASTS; OSTEOCALCIN; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032200715     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02347.x     Document Type: Article

References (44)

1. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease: summary of current work. Lab Invest 1976;34:235-249.
2. Listgarten MA. Pathogenesis of periodontitis. J Clin Periodontal 1986;13:418-425.
3. Gottlow J. Principles of regenerative therapy. In: Genco R, Hamada S, Lehner T, McGhee J, Mergenhagen S, eds. Molecular pathogenesis of periodontal disease. Washington DC: ASM Press 1994;393-401.
4. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971:50:1392-1406.
5. Wozney JM. Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-1534.
6. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995;77-A:734-750.
7. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Arch Otolaryngol Head Neck Surg 1991;117:1101-1112.
8. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-2224.
9. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2); a radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1992;74-A:659-670.
10. Gerhart TN, Kirker-Head CA, Kriz MJ, et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993;293:317-326.
11. Hiraki Y, Inoue H, Shigeno C, et al. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 1991;6:1373-1385.
12. Katagiri T, Yamaguchi A, Ikeda T, et al. The nonosteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990;172:295-299.
13. Katagiri T, Yamaguchi A, Komaki M, et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-1766.
14. Knutsen R, Wergedal JE, Sampath TK, Baylink DJ, Mohan S. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochem Biophys Res Commun 1993;194:1352-1358.
15. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity, and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 1991;174:96-101.
16. Thies RS, Bauduy M, Ashton BA, Kurtzbcrg L, Wozney JM, Rosen V. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992;130:1318-1324.
17. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 1993;9:57-71.
18. Yamaguchi A, Katagiri T, Ikeda T, et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-687.
19. Yamaguchi A, Ishizuya T, Kintou N, et al. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell line, ST2 and MC3T3-G2/PA6. Biochem Biophvs Res Commun 1996;220:366-371.
20. Sigurdsson TJ, Tatakis DN, Lee MB. Wikesjö UME. Periodontal regenerative potential of space-providing expanded polytetrafluoroethylene membranes and recombinant human bone morphogenetic proteins. J Periodontol 1995;66:511-521.
21. Sigurdsson TJ, Lee MB, Kubota K. Turek TJ, Wozney JM. Wikesjö UME. Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J Periodontol 1995;66:131-138.
22. Kinoshita A, Oda S, Takahashi K, Yokota S, Ishikawa I. Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in Beagle dogs. J Periodontol 1997;68:103-109.
23. Boynton E, Aubin J, Gross A, Hozumi N, Sandhu J. Human osteoblasts survive and deposit new bone when human bone is implanted in SCID mouse. Bone 1996;18:321-326.
24. de Pollak C, Arnaud E, Renier D, Marie PJ. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. J Cell Biochem 1997;64:128-139.
25. Fedarko NS, Vetter UK. Weibstein S, Gehron RP. Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J Cell Physiol 1992;151:215-227.
26. D'avis PY, Frazier CR, Shapiro JR, Fedarko NS. Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells. Biochem J 1997;324:753-760.
27. Kasperk C, Wergedal JE, Strong D, et al. Human bone cell phenotypes differ depending on their skeletal site of origin. J Clin Endocrinol Metab 1995;80:2511-2517.
28. Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S. Insulin-like growth factor (IGF)- I, -II. IGF binding protein (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. J Bone Miner Res 1997;12:423-430.
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
30. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-352.
31. Fukumoto S, Suzawa M, Takeuchi Y, et al. Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor complementary deoxyribonucleic acid in patients with pseudohypoparathyroidsm type Ib. J Clin Endocrinol Metab 1996;81:2554-2558.
32. Celeste AJ, Rosen V, Buecker JL, Kriz R, Wang EA, Wozney JM. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 1986;5:1885-1890.
33. Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG, Liotta LA. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa Type IV collagenase, gelatinase A). J Biol Chem 1994:269:21505-21511.
34. Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int 1985;37:453-460.
35. Ahrens M, Ankenbauer T, Schröder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic proteion-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993;12:871-880.
36. Lecanda F, Avioli LV, Cheng SL. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 1997;67:386-398.
37. Amedee J, Bareille R, Rouais F, Cunningham N, Reddi H, Harmand MF. Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow. Differentiation 1994;58:157-164.
38. 3, recombinant human bone morphogenetic protein-2, or ipriflavone. Bone 1998;22:251-258.
39. Varghese S, Ramsby ML, Jeffrey JJ, Canalis E. Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 1995;136:2156-2162.
40. Canalis E, Rydziel S, Delany AM, Varghese S, Jeffrey JJ. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures Endocrinology 1995;136:1348-1354.
41. Varghese S, Delany AM, Liang L, Gabbitas B, Jeffrey JJ, Canalis E. Transcriptional and posttranscriptionai regulation of interstitial collagenase by platelet-derived growth factor BB in bone cell cultures. Endocrinology 1996;137:431-437.
42. Rydziel S, Varghese S, Canalis E. Transforming growth factor β1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures. J Cell Physiol 1997;170:145-152.
43. Delany AM, Rydziel S, Canalis E. Autocrine down-regulation of collagenase-3 in rat bone cell cultures by insulin-like growth factors. Endocrinology 1996;137:4665-4670.
44. Varghese S, Canalis E. Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. Endocrinology 1997;138:1035-1040.